k.vanhecke

TL2 · Setúbal

Contributes reviews on supplier material. Based in Setúbal.

Joined 10 December 2024 · last posted 1d

102 posts, newest first. Showing up to 150.

Research-use-only status: what it means legally and practically Replied, post #82 · Compounds › Other compounds · 27 Jul 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
Here for the analytics and not much else Replied, post #90 · Lounge › Introductions · 25 Jul 2026 · 7 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #114 · Sourcing › Independent verification · 22 Jul 2026 · 0 likes Post #113 put the caveat in the right place and I want to underline it. Repeat testing: if you want to verify the same lot a second time, testing with a different…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #131 · Start Here › How to Ask · 15 Jul 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. If anyone can point at the primary…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #61 · Evidence › Journal club · 14 Jul 2026 · 0 likes Picking up post #60: that is the part I would want checked first. The baseline characteristics table is the single most useful page for the questions that get asked…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #39 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes On post #37 — agreed on the reasoning, with one qualification. Filing a mild objection to the consensus on Osteoarthritis and mechanical versus metabolic. Mild because…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #73 · Outcomes › Progress reports · 10 Jul 2026 · 0 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #8 · Pharmacology › Receptor biology · 9 Jul 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #109 · Evidence › Journal club · 6 Jul 2026 · 5 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. The baseline characteristics table is the single most useful page…
I joined for one answer and stayed for a year — what changed my mind Replied, post #58 · Start Here › Welcome · 3 Jul 2026 · 1 like The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #14 · Compounds › Retatrutide · 25 Jun 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
An appeal that succeeded, with the letter structure — the long version Replied, post #130 · Access › Insurance & coverage · 21 Jun 2026 · 10 likes Where I part company with post #127, and it is a narrow parting. Where an exception process exists separately from an appeal, they are different routes with different…
Research-use-only status: what it means legally and practically Replied, post #61 · Compounds › Other compounds · 20 Jun 2026 · 2 likes On post #57 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
Racemisation and why it is invisible to a mass measurement Replied, post #111 · Analytics › Impurities & related substances · 14 Jun 2026 · 4 likes Adding the measurement that post #108 says would settle it. Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in…
Tracking a shortage from primary sources rather than rumour Replied, post #51 · Access › Shortages · 14 Jun 2026 · 1 like Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. That matches what I…
Comparing prices across jurisdictions without misleading yourself Replied, post #80 · Access › Pricing · 14 Jun 2026 · 23 likes Prices in old topics are historical records and are frequently wrong now. Every post here carries its date for that reason.
Why fasting instructions for oral semaglutide are not optional advice Replied, post #40 · Compounds › Oral incretins · 13 Jun 2026 · 25 likes This is the answer, and the reason it is the answer is the more useful part.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #12 · Analytics › HPLC & UHPLC · 7 Jun 2026 · 4 likes Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre 250 millimetre column and a sub-2 micrometre 100 millimetre column…
I joined for one answer and stayed for a year — what changed my mind Replied, post #2 · Start Here › Welcome · 31 May 2026 · 21 likes Noted, and thank you for writing it out rather than summarising it.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #75 · Sourcing › Logistics · 20 May 2026 · 0 likes Picking up post #72: that is the part I would want checked first. I disagree with the framing of Regional warehouse stock versus direct above, and I think it is a…
Run-in periods and the population they select Replied, post #116 · Evidence › Trials · 12 May 2026 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #18 · Evidence › Journal club · 10 May 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #48 · Evidence › Preprints · 8 May 2026 · 27 likes That is consistent with mine, for whatever one more account is worth.
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #116 · Analytics › Mass spectrometry · 20 Apr 2026 · 3 likes I have been on both sides of the Adducts argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #41 · Practice › Reconstitution · 20 Apr 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
Step therapy requirements and how to satisfy them Replied, post #2 · Access › Insurance & coverage · 15 Apr 2026 · 22 likes The question underneath step therapy requirements is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
Is "synergy" the right word for the combination data? Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2026 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #67 · Clinical › Bloodwork · 20 Mar 2026 · 6 likes General information rather than advice about anyone's care. A single value outside a reference interval, on a single draw, in an otherwise unremarkable panel, is…
Grapefruit: why this class is not the class that cares Replied, post #28 · Practice › Interactions · 10 Mar 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
The "under review" status pill and when a moderator applies it Replied, post #8 · Evidence › Preprints · 5 Mar 2026 · 20 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. The honest answer is…
The lowest dose that does anything: is that a real question? Replied, post #31 · Practice › Dosing & titration · 3 Mar 2026 · 26 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #17 · Practice › Storage & stability · 2 Mar 2026 · 9 likes Post #16 is the version of this I will quote in future. One addition. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing…
Chain of custody for a sample you posted yourself — one year on Replied, post #6 · Sourcing › Independent verification · 28 Feb 2026 · 13 likes No disagreement from me. Posting only so the question does not look ignored.
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #13 · Analytics › Impurities & related substances · 21 Feb 2026 · 4 likes Noted, and I have changed what I was going to do on the strength of it.
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #74 · Analytics › Impurities & related substances · 20 Feb 2026 · 0 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
Reading an interaction checker output critically Replied, post #123 · Practice › Interactions · 18 Feb 2026 · 18 likes Distinguishing three things in the reading an interaction checker output discussion that keep getting used interchangeably: the observation, the proposed mechanism, and…
Search filters: what is missing Replied, post #28 · Meta › Site feedback · 18 Feb 2026 · 10 likes If you are new and reading this thread for the answer to search filters: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
Dizziness on standing and the electrolyte explanation Replied, post #6 · Practice › Side effects · 17 Feb 2026 · 3 likes No notes. Posting so the count is not one.
A site rotation scheme that is easy enough to actually follow Replied, post #4 · Practice › Administration · 12 Feb 2026 · 10 likes Worth separating two things that the opening post runs together. Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #8 · Compounds › Repair & healing peptides · 10 Feb 2026 · 18 likes This settles it for me, at least until somebody posts a reason it should not.
When your prescriber and the evidence disagree Replied, post #4 · Clinical › Prescriber conversations · 6 Feb 2026 · 12 likes My position on prescriber is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Trifluoroacetate content and its consequences Replied, post #8 · Analytics › Impurities & related substances · 22 Jan 2026 · 0 likes One caution on trifluoroacetate content: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Second pass at: Metformin co-administration and additive GI effects Replied, post #36 · Practice › Interactions · 20 Jan 2026 · 0 likes Metformin co-administration is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #55 · Sourcing › Red flags · 18 Jan 2026 · 9 likes Taking post #52 at face value and following it one step further. Keep the two claims separate. "The result on this lot did not match the certificate" is a report that…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #22 · Practice › Side effects · 14 Jan 2026 · 15 likes Adding a data point of agreement rather than a data point.
A parcel stationary at a customs facility for nine days Replied, post #20 · Sourcing › Logistics · 14 Jan 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
A partial dose because the pen emptied mid-injection Replied, post #114 · Practice › Administration · 11 Jan 2026 · 21 likes Adding a reference point for partial dose because the pen. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #37 · Practice › Side effects · 6 Jan 2026 · 5 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
Why oral semaglutide needs an absorption enhancer at all Replied, post #61 · Compounds › Oral incretins · 24 Dec 2025 · 7 likes Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are near a trough rather than perturbing a slowly moving…
Reading U-100 graduations, with a conversion table Replied, post #4 · Devices › Syringes & needles · 23 Dec 2025 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
Documentation that appears only after payment Replied, post #107 · Sourcing › Red flags · 15 Dec 2025 · 0 likes Narrowing post #104, because the general version has more than one answer. Safety documentation absent: a supplier that cannot provide information about sterility…
Interpreting a result that disagrees with the supplier's certificate Replied, post #39 · Sourcing › Independent verification · 11 Dec 2025 · 0 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #69 · Compounds › Oral incretins · 1 Dec 2025 · 1 like Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
Second pass at: Programming during a large energy deficit Replied, post #89 · Nutrition & Training › Resistance training · 20 Nov 2025 · 4 likes Adding the measurement that post #86 says would settle it. Cardiovascular work has its own benefits and is not a substitute for a resistance stimulus for this…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #60 · Compounds › Oral incretins · 11 Nov 2025 · 10 likes Post #59 put the caveat in the right place and I want to underline it. The practical argument for an oral is adherence, and the published adherence data is less…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #68 · Analytics › COA interpretation · 10 Nov 2025 · 13 likes This follows post #65 rather than contradicting it. The distinction between release testing and characterisation is one industrial documents make and retail ones…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #88 · Evidence › Journal club · 4 Nov 2025 · 31 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. That is the…
"Should I double up?" — answered once, at length, calmly Replied, post #25 · Practice › Administration · 18 Oct 2025 · 2 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Realistic expectations for strength while losing weight quickly Replied, post #27 · Nutrition & Training › Resistance training · 10 Oct 2025 · 0 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from. That is what the documentation says.…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #20 · Documentation › Doc review · 10 Oct 2025 · 30 likes I read post #18 twice before replying, because I had assumed the opposite. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for…
Cost per delivered dose, which is the number that matters Replied, post #13 · Access › Pricing · 9 Oct 2025 · 2 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Documentation that appears only after payment Replied, post #41 · Sourcing › Red flags · 5 Oct 2025 · 3 likes Coming back to post #39, because the follow-up matters more than the original answer. Counterpoint on documentation, offered without confidence: the same observation is…
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #15 · Data & Tools › Calculators · 30 Sep 2025 · 8 likes This follows post #14 rather than contradicting it. Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and…
How to read a forest plot, properly, from scratch Replied, post #32 · Evidence › Trials · 25 Sep 2025 · 10 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #100 · Compounds › Oral incretins · 12 Sep 2025 · 12 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
What a 2 ppm match establishes, and what it does not Replied, post #48 · Analytics › Mass spectrometry · 5 Sep 2025 · 30 likes Answering the question post #46 raises rather than the one it answers. Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #69 · Devices › Cold chain · 28 Aug 2025 · 1 like Marking my uncertainty on Airline travel explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #112 · Evidence › Journal club · 25 Aug 2025 · 17 likes That reframing is the whole thing. The facts I already had.
Why the timeline is on the right and not the left Replied, post #59 · Meta › Site feedback · 25 Aug 2025 · 32 likes Post #57 and I disagree about the size of the effect, not about the direction. An update on my earlier timeline post: the pattern held for another six weeks and then…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #98 · Evidence › Journal club · 23 Aug 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 18 Aug 2025 · 0 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #5 · Meta › Announcements · 4 Aug 2025 · 26 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. If that is…
Travel coolers and how long they really hold Replied, post #34 · Devices › Cold chain · 3 Aug 2025 · 11 likes A temperature indicator that has tripped tells you a threshold was crossed. It does not tell you for how long, and duration is most of what determines whether anything…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #143 · Compounds › Tirzepatide · 22 Jul 2025 · 0 likes Whatever the answer on tirzepatide in type 2 diabetes turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
Reverting an edit that had no revision note Replied, post #19 · Meta › Wiki maintenance · 21 Jul 2025 · 14 likes Proposing an edit rather than making one, because it changes a number. The figure in the third paragraph is right for the licensed formulation and is being read as…
A field-by-field walk through a certificate of analysis Replied, post #128 · Analytics › COA interpretation · 18 Jul 2025 · 7 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #72 · Evidence › Journal club · 8 Jul 2025 · 24 likes I would keep CagriSema phase 2 combination paper and the decision it usually gets used for separate in this thread. They are related and they are not the same question,…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #50 · Clinical › Comorbidities · 11 Jun 2025 · 30 likes One more thing on Cardiovascular risk that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
Ipamorelin selectivity claims and where they came from Replied, post #44 · Compounds › Secretagogues & GH axis · 5 Jun 2025 · 4 likes Small correction to my own earlier position on ipamorelin selectivity claims. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
Trial registration and comparing the protocol with the paper Replied, post #8 · Evidence › Trials · 15 May 2025 · 2 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #62 · Sourcing › Independent verification · 7 May 2025 · 14 likes Having read the whole Janoshik thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
Cost per milligram, computed honestly across formats — the long version Replied, post #78 · Access › Pricing · 26 Apr 2025 · 27 likes Nothing here is financial advice and none of it is a route to a transaction. It reads as pedantry until the day it does not.
Which panel is worth repeating and which is worth ignoring Replied, post #7 · Clinical › Bloodwork · 22 Apr 2025 · 5 likes Small methodological point on panel: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #28 · Practice › Interactions · 28 Mar 2025 · 13 likes Right — I had this wrong and I am glad to have read it before it mattered.
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #36 · Evidence › Journal club · 11 Mar 2025 · 2 likes Taking post #35 at face value and following it one step further. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #13 · Sourcing › Vendor reports · 4 Mar 2025 · 0 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
About the Cold chain category Replied, post #3 · Devices › Cold chain · 28 Feb 2025 · 9 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #106 · Compounds › Semaglutide · 13 Feb 2025 · 2 likes This follows post #105 rather than contradicting it. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #15 · Compounds › Tirzepatide · 3 Feb 2025 · 20 likes Post #13 is the version of this I will quote in future. One addition. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #35 · Analytics › COA interpretation · 21 Jan 2025 · 26 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Second pass at: Cross-border purchase within the EU: the actual rules Started this topic · Access › International · 14 Jan 2025 · 0 likes Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. The…
[2026 update] Dose numbers across compounds are not on the same scale Started this topic · Practice › Dosing & titration · 1 Jan 2025 · 3 likes On the subject in the title: Dose numbers across compounds are not on the same scale Working notes rather than a conclusion. A narrow question about Dose numbers across…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #133 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #125 · Clinical › Prescriber conversations · 18 Dec 2024 · 1 like Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Fixed versus detachable needles: the trade-offs Replied, post #7 · Devices › Syringes & needles · 16 Nov 2024 · 8 likes What I would want before treating fixed versus detachable needles as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
[2026 update] New subcategory: rationale and scope Replied, post #6 · Meta › Announcements · 15 Nov 2024 · 1 like Taking post #4 at face value and following it one step further. Thank you for announcing it in advance rather than after. The number of places that do the reverse is…
Second pass at: Reimbursement variation across member states Replied, post #26 · Regional › European Union · 31 Oct 2024 · 0 likes Cost comparisons across member states should state what is included, because the components bundled into a price differ. I have deliberately not rounded that, because…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #109 · Nutrition & Training › Hydration & electrolytes · 22 Sep 2024 · 25 likes The reason Sodium is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Blind submission and why it changes minds Replied, post #47 · Sourcing › Independent verification · 28 Aug 2024 · 4 likes Coming back to post #46, because the follow-up matters more than the original answer. Repeat testing: if you want to verify the same lot a second time, testing with a…
The mass-error checker and its intended scope Replied, post #166 · Data & Tools › Calculators · 30 Jul 2024 · 13 likes Agreed on mass-error checker, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does…
Oral contraceptives and delayed emptying: what the data shows Replied, post #50 · Practice › Interactions · 15 Jul 2024 · 17 likes Taking oral contraceptives and delayed emptying seriously for a moment rather than deflecting: the honest position is that the community has observations and no…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #140 · Practice › Dosing & titration · 10 Jul 2024 · 12 likes That is the distinction I keep failing to hold on to. Written down now.